ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
97,303.61
-0.17%
S&P 500
5,953.05
1.47%
Dow Jones
42,979.54
1.51%
US Dollar vs Yen
156.037
-1.03%
Brent Oil
72.615
0.32%
Registration Strip Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ
  6. Clearside Biomedical Inc (CLSD)

  7. Clearside Biomedical Inc (CLSD) ニュース

CLSD

Clearside Biomedical (CLSD)

Clearside Biomedical Inc
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NASDAQ:CLSD
日付受信時刻ニュースソース見出しコード企業名
2024/12/1921 : 05GlobeNewswire Inc.Clearside Biomedical Announces Publication of Critical Insights into Retinal Drug Development in the Peer-Reviewed Scientific Journal, EyeNASDAQ:CLSDClearside Biomedical Inc
2024/11/2521 : 05GlobeNewswire Inc.Clearside Biomedical Extends Global Footprint with Numerous Presentations at Medical Meetings in Asia, Europe and the United StatesNASDAQ:CLSDClearside Biomedical Inc
2024/11/1306 : 10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CLSDClearside Biomedical Inc
2024/11/1306 : 05GlobeNewswire Inc.Clearside Biomedical Announces Third Quarter 2024 Financial Results and Provides Corporate UpdateNASDAQ:CLSDClearside Biomedical Inc
2024/11/0723 : 05GlobeNewswire Inc.Clearside Biomedical Partner Arctic Vision Executes Commercial Collaboration Agreement with Santen Pharmaceutical Co., Ltd for ARVN001 Suprachoroidal Space Injection Therapy for the Treatment of Uveitic Macular EdemaNASDAQ:CLSDClearside Biomedical Inc
2024/11/0621 : 05GlobeNewswire Inc.Clearside Biomedical to Participate in Fireside Chat at the Stifel 2024 Healthcare ConferenceNASDAQ:CLSDClearside Biomedical Inc
2024/11/0506 : 15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CLSDClearside Biomedical Inc
2024/11/0421 : 05GlobeNewswire Inc.Clearside Biomedical Appoints Tony Gibney as New Chair of the Board of DirectorsNASDAQ:CLSDClearside Biomedical Inc
2024/10/3120 : 05GlobeNewswire Inc.Clearside Biomedical to Report Third Quarter 2024 Financial Results and Provide Corporate Update on Tuesday, November 12, 2024NASDAQ:CLSDClearside Biomedical Inc
2024/10/2220 : 05GlobeNewswire Inc.Clearside Biomedical’s Positive ODYSSEY Wet AMD Data and Suprachoroidal Injection Platform Highlighted in Presentations at Multiple Events During AAO 2024 Annual MeetingNASDAQ:CLSDClearside Biomedical Inc
2024/10/0920 : 55Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CLSDClearside Biomedical Inc
2024/10/0919 : 30GlobeNewswire Inc.Clearside Biomedical Announces Positive Topline Results from ODYSSEY Phase 2b Trial of Suprachoroidal CLS-AX in Wet AMD Achieving All Primary and Secondary OutcomesNASDAQ:CLSDClearside Biomedical Inc
2024/08/2720 : 05GlobeNewswire Inc.Clearside Biomedical Announces Completion of Final Participant Visit in ODYSSEY Phase 2b Trial of CLS-AX in Wet AMDNASDAQ:CLSDClearside Biomedical Inc
2024/08/1305 : 30Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CLSDClearside Biomedical Inc
2024/08/1305 : 15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CLSDClearside Biomedical Inc
2024/08/1305 : 05GlobeNewswire Inc.Clearside Biomedical Announces Second Quarter 2024 Financial Results and Provides Corporate UpdateNASDAQ:CLSDClearside Biomedical Inc
2024/08/0820 : 05GlobeNewswire Inc.Clearside Biomedical to Participate in the H.C. Wainwright 4th Annual Ophthalmology Virtual ConferenceNASDAQ:CLSDClearside Biomedical Inc
2024/08/0120 : 05GlobeNewswire Inc.Clearside Biomedical to Report Second Quarter 2024 Financial Results on Monday, August 12, 2024NASDAQ:CLSDClearside Biomedical Inc
2024/07/3005 : 05GlobeNewswire Inc.Clearside Biomedical’s Partner Arctic Vision Reports Positive Topline Results from Phase 3 Clinical Trial of ARCATUS® for Suprachoroidal Use in Uveitic Macular Edema Patients in ChinaNASDAQ:CLSDClearside Biomedical Inc
2024/07/2420 : 55Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CLSDClearside Biomedical Inc
2024/07/2301 : 00GlobeNewswire Inc.Clearside Biomedical Opens Registration for Suprachoroidal Delivery KOL Webinar to Be Held on Wednesday, July 24, 2024 at 8:00 am ETNASDAQ:CLSDClearside Biomedical Inc
2024/07/1120 : 05GlobeNewswire Inc.Clearside Biomedical Appoints Dr. Glenn Yiu to its Scientific Advisory BoardNASDAQ:CLSDClearside Biomedical Inc
2024/06/2720 : 05GlobeNewswire Inc.Clearside Biomedical to Host Virtual Key Opinion Leader Event on the Use and Versatility of Suprachoroidal Drug DeliveryNASDAQ:CLSDClearside Biomedical Inc
2024/06/1220 : 05GlobeNewswire Inc.Clearside Biomedical’s Leadership in Suprachoroidal Delivery Featured in Multiple Presentations at the Clinical Trials at the Summit MeetingNASDAQ:CLSDClearside Biomedical Inc
2024/05/2120 : 05GlobeNewswire Inc.Clearside Biomedical Announces Publication of Consensus Guidelines for Drug Delivery via Suprachoroidal Space (SCS®) Injection in Leading Peer-Reviewed Industry Journal, RETINA®NASDAQ:CLSDClearside Biomedical Inc
2024/05/1105 : 31Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:CLSDClearside Biomedical Inc
2024/05/1005 : 10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CLSDClearside Biomedical Inc
2024/05/1005 : 05GlobeNewswire Inc.Clearside Biomedical Announces First Quarter 2024 Financial Results and Provides Corporate UpdateNASDAQ:CLSDClearside Biomedical Inc
2024/05/0905 : 15GlobeNewswire Inc.Clearside Biomedical to Participate in Fireside Chat at the Citizens JMP Life Sciences ConferenceNASDAQ:CLSDClearside Biomedical Inc
2024/04/3020 : 05GlobeNewswire Inc.Clearside Biomedical to Report First Quarter 2024 Financial Results and Provide Corporate Update on Thursday, May 9, 2024NASDAQ:CLSDClearside Biomedical Inc
 Showing the most relevant articles for your search:NASDAQ:CLSD

最近閲覧した銘柄

CCOM
US500
US 500
SPI
SP500
S&P 500
NYSE
CVX
Chevron
NASDAQ
TSLA
Tesla
NYSE
VZ
Verizon Communications
CCOM
US30
US 30
CCOM
SILVER
SILVER
USOTC
BNPQY
BNP Paribas (QX)
NYSE
DIS
Walt Disney
USI
USTECH100
US Tech 100
COIN
ETHUSD
Ethereum
NASDAQ
NVDA
NVIDIA
USOTC
RHHBY
Roche (QX)
NASDAQ
GOOGL
Alphabet
NASDAQ
QQQ
Invesco QQQ Trust Series 1
FX
USDJPY
US Dollar vs Yen
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

日本
会社情報
ビジネス
人気
アプリを入手
App Store
Google Play

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有